GO:0061724 lipophagy: Selective Lipid Droplet Degradation, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061724 lipophagy is the selective degradation of lipid droplets by macroautophagy, as defined by QuickGO.
• Lipophagy mobilizes stored lipids into free fatty acids for energy production or extracellular secretion [4,8].
• Key regulators include ATG proteins, Rab7, and lipid droplet-associated factors such as PLIN2 and PLIN3.
• Impaired lipophagy contributes to atherosclerosis, nonalcoholic steatohepatitis, and diabetes-associated cognitive impairment [1,2,3,4,7].
• Experimental models include CRISPR knockout, point mutation, knock-in, and overexpression cell lines to dissect causal roles of lipophagy genes.
• Methods such as Ribo-seq, RNA-seq, proteomics, and live-cell imaging are used to study lipophagy dynamics and regulation.
Description
Lipophagy, formally annotated as GO:0061724, is a selective form of macroautophagy that specifically targets lipid droplets for lysosomal degradation. This process is critical for cellular lipid homeostasis, enabling cells to mobilize stored triglycerides and cholesteryl esters into free fatty acids and cholesterol for energy production, membrane synthesis, or secretion [4,8]. Since its initial description, lipophagy has emerged as a central mechanism in metabolic disorders, including atherosclerosis, nonalcoholic steatohepatitis (NASH), and diabetes-associated cognitive impairment [1,2,3,4,7]. Researchers study lipophagy to understand how cells adapt to nutrient stress, how lipid overload contributes to disease, and how pharmacological or genetic interventions can modulate lipid droplet turnover [5,6]. The QuickGO definition states that lipophagy is the selective degradation of lipid droplets by macroautophagy, distinguishing it from general autophagy and from cytosolic lipases. This article provides a research-grade overview of lipophagy, covering its molecular machinery, key genes, disease relevance, and state-of-the-art methods including CRISPR-based models.
lipophagy At A Glance
| GO ID | GO:0061724 |
|---|---|
| GO term | lipophagy |
| Ontology | biological_process |
| Synonym | none |
| Major function | Selective degradation of lipid droplets by macroautophagy |
| Related processes | Macroautophagy, lipid catabolism, cholesterol efflux |
| Key regulators | ATG proteins, Rab7, PLIN2, PLIN3, TREM1 |
| Disease relevance | Atherosclerosis, NASH, diabetes-associated cognitive impairment |
What Is GO:0061724?
According to the Gene Ontology (QuickGO), lipophagy (GO:0061724) is defined as the selective degradation of lipid droplets by macroautophagy. In other words, it is a specialized autophagic process in which lipid droplets, the intracellular organelles that store neutral lipids, are engulfed by autophagosomes and delivered to lysosomes for breakdown. This definition distinguishes lipophagy from general autophagy, which degrades bulk cytoplasm or damaged organelles, and from neutral lipases that act directly on lipid droplets [5,6].
Why Is lipophagy Important in Cell Biology?
Lipophagy is essential for cellular lipid homeostasis and energy balance. It allows cells to break down lipid droplets when nutrients are scarce, providing fatty acids for mitochondrial beta-oxidation or for secretion [4,8]. Dysregulation of lipophagy is increasingly linked to major human diseases, including atherosclerosis, nonalcoholic steatohepatitis, and diabetes-associated cognitive impairment [1,2,3,4,7]. Understanding lipophagy at the molecular level is therefore critical for developing therapeutic strategies that target lipid metabolism.
• Maintains cellular energy balance by mobilizing lipid stores during nutrient deprivation.
• Prevents lipid droplet accumulation and lipotoxicity in hepatocytes and macrophages [4,6].
• Facilitates cholesterol efflux from macrophage foam cells, protecting against atherosclerosis [2,6].
• Contributes to extracellular lipid secretion from the liver, ameliorating NASH.
• Its impairment in microglia leads to TREM1 buildup and cognitive decline in diabetes.
• Disruption of lipophagy by ASIC1/RIP1 signaling accelerates atherosclerosis.
• Provides a target for therapeutic intervention in metabolic disorders.
• Serves as a paradigm for selective autophagy of organelles.
• Involves crosstalk with lysosomal exocytosis for fatty acid efflux.
• Can be studied using CRISPR-based gene editing to dissect causal roles.
What Happens During lipophagy?
Initiation and cargo recognition
In simple terms: The cell marks lipid droplets for destruction.
Lipophagy begins with the recognition of lipid droplets as cargo for autophagic degradation. This process requires the core autophagy machinery, including ATG proteins, and is regulated by nutrient-sensing pathways. Lipid droplet-associated proteins such as PLIN2 and PLIN3 are implicated in cargo selection and regulation of lipophagy. In macrophages, novel lipid droplet factors that regulate lipophagy and cholesterol efflux have been identified.
Autophagosome formation and engulfment
In simple terms: A double-membrane sac wraps around the lipid droplet.
Following initiation, a phagophore expands to engulf the lipid droplet, forming an autophagosome. This step depends on ATG conjugation systems and the lipidation of LC3/GABARAP proteins. The autophagosome then fuses with lysosomes to form an autolysosome, where lipid hydrolysis occurs. Rab7 is involved in autophagosome-lysosome fusion and is important for lipophagy.
Lysosomal degradation and fatty acid release
In simple terms: The lipid droplet is broken down inside the lysosome, releasing fatty acids.
Within the autolysosome, lysosomal acid lipases hydrolyze triglycerides and cholesteryl esters into free fatty acids and cholesterol. These products can be used for energy production, membrane synthesis, or secreted extracellularly [4,8]. Lipophagy-derived fatty acids can undergo extracellular efflux via lysosomal exocytosis.
Extracellular lipid secretion
In simple terms: Some fatty acids are exported out of the cell.
In hepatocytes, lipophagy promotes the secretion of lipids into the extracellular space, which can ameliorate nonalcoholic steatohepatitis. This pathway involves lysosomal exocytosis and provides a mechanism for lipid disposal beyond intracellular catabolism.
Key Genes Involved in GO:0061724 lipophagy
The following genes and proteins are central to lipophagy, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG5 | Core autophagy machinery; required for autophagosome formation | Knockout blocks lipophagy and increases lipid droplet accumulation |
| ATG7 | Essential for LC3 lipidation and autophagosome elongation | Conditional knockout models show impaired lipophagy in liver |
| LC3B (MAP1LC3B) | Autophagosome marker; involved in cargo recruitment | Used as a readout for autophagosome formation during lipophagy |
| PLIN2 | Lipid droplet coat protein; regulates lipophagy | Knockdown increases lipophagy and cholesterol efflux |
| PLIN3 | Lipid droplet-associated protein; modulates lipophagy | Identified as a novel regulator of lipophagy in macrophages |
| Rab7 | Late endosome/lysosome fusion; required for autolysosome formation | Knockdown impairs lipophagy and cholesterol efflux |
| TREM1 | Inflammatory receptor; accumulates when lipophagy is impaired | Linked to diabetes-associated cognitive impairment |
| ASIC1 | Acid-sensing ion channel; disrupts lipophagy via RIP1 | Promotes atherosclerosis by inhibiting lipophagy |
| RIP1 (RIPK1) | Kinase involved in inflammation and cell death; inhibits lipophagy | ASIC1/RIP1 axis accelerates atherosclerosis |
| LAMP1 | Lysosomal membrane protein; marker for lysosomes | Used to assess autolysosome formation |
| LAMP2 | Lysosomal membrane protein; involved in chaperone-mediated autophagy | May influence lipophagy efficiency |
| CTSB | Lysosomal protease; can degrade lipid droplet proteins | Potential role in lipophagy-mediated lipid breakdown |
| LIPA (LAL) | Lysosomal acid lipase; hydrolyzes cholesteryl esters and triglycerides | Key enzyme for lipid hydrolysis in lipophagy |
| UVRAG | Autophagy regulator; promotes autophagosome maturation | May enhance lipophagy |
| BECN1 (Beclin-1) | Autophagy initiation; part of PI3K complex | Overexpression stimulates lipophagy |
| SQSTM1 (p62) | Selective autophagy receptor; may recognize ubiquitinated lipid droplet proteins | Knockout affects selective autophagy |
| NBR1 | Selective autophagy receptor; similar to p62 | Potential role in lipid droplet recognition |
How Is lipophagy Regulated?
Lipophagy is regulated by nutrient-sensing pathways, including mTORC1, which inhibits autophagy under nutrient-rich conditions, and AMPK, which activates autophagy during energy stress. In macrophages, inflammatory signaling through ASIC1/RIP1 disrupts lipophagy, contributing to atherosclerosis. Additionally, lipid droplet-associated proteins such as PLIN2 and PLIN3 modulate lipophagy efficiency. The transcription factor TFEB promotes lysosomal biogenesis and autophagy, indirectly enhancing lipophagy.
lipophagy and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TREM1 | Diabetes-associated cognitive impairment | Microglial-specific knockout or overexpression in diabetic mice |
| ASIC1 | Atherosclerosis | ApoE-/- mice with ASIC1 knockout or pharmacological inhibition |
| PLIN2 | Atherosclerosis, cholesterol efflux | Macrophage-specific knockout or knockdown |
| ATG7 | Nonalcoholic steatohepatitis | Liver-specific conditional knockout |
| LIPA | Lysosomal acid lipase deficiency (CESD/Wolman) | Patient-derived fibroblasts or CRISPR knock-in of disease mutations |
Atherosclerosis
Impaired lipophagy in macrophage foam cells leads to excessive lipid droplet accumulation and reduced cholesterol efflux, promoting atherosclerotic plaque formation [2,3,6]. ASIC1/RIP1 signaling disrupts lipophagy and accelerates atherosclerosis in mouse models. Targeting lipophagy may therefore be a therapeutic strategy for cardiovascular disease [2,3].
Nonalcoholic steatohepatitis (NASH)
In the liver, lipophagy facilitates the secretion of lipids into the extracellular space, reducing hepatic steatosis and inflammation. Enhancing liver lipophagy ameliorates NASH in preclinical models. Conversely, defective lipophagy contributes to lipid overload and liver injury.
Diabetes-associated cognitive impairment
In diabetes, impaired lipophagy in microglia leads to lipid droplet accumulation and the buildup of TREM1, which promotes neuroinflammation and cognitive decline. Restoring lipophagy may mitigate these effects.
From lipophagy-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate lipophagy? | CRISPR knockout cell lines (e.g., HepG2, RAW264.7) followed by lipid droplet imaging |
| Does a specific mutation in gene Y affect lipophagy? | Point mutation knock-in via CRISPR in isogenic cell lines |
| How does gene Z overexpression affect lipid storage? | Doxycycline-inducible overexpression in hepatocytes or macrophages |
| What is the role of gene W in atherosclerosis? | ApoE-/- or LDLR-/- mouse models with CRISPR-mediated gene editing |
| Does gene V mediate lipophagy-derived fatty acid efflux? | Knockout of V in HeLa or HepG2 cells, followed by lysosomal exocytosis assays |
| Can a tagged version of protein U track lipophagy? | CRISPR knock-in of fluorescent tag (e.g., GFP) at endogenous locus |
How to Study the lipophagy Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy (BODIPY + LC3) | Colocalization of lipid droplets and autophagosomes | Visualizing lipophagy in fixed or live cells |
| Western blot (LC3-II, p62) | Autophagic flux | Assessing lipophagy induction or inhibition |
| Lipid droplet isolation and proteomics | Protein composition of lipid droplets | Identifying novel lipophagy regulators |
| RNA-seq | Transcriptional changes during lipophagy | Discovering pathways and gene signatures |
| CRISPR knockout screen | Genes required for lipophagy | High-throughput discovery of regulators |
| Free fatty acid release assay | Lipolysis and efflux | Measuring lipophagy-derived fatty acid secretion [4,8] |
| Lysosomal exocytosis assay | Extracellular release of lysosomal contents | Studying lipophagy-derived fatty acid efflux |
| Transmission electron microscopy | Ultrastructure of autophagosomes and lipid droplets | Confirming lipophagy at high resolution |
Imaging lipid droplets and autophagosomes
Fluorescence microscopy using BODIPY or LipidTOX to label lipid droplets, combined with GFP-LC3 or mCherry-LC3 to visualize autophagosomes, allows real-time monitoring of lipophagy [5,6]. Live-cell imaging can track the engulfment of lipid droplets by autophagosomes.
Biochemical assays for lipophagy flux
Western blotting for LC3-II, p62, and lipid droplet proteins (e.g., PLIN2) in the presence and absence of lysosomal inhibitors (e.g., chloroquine) measures autophagic flux. Lipophagy can also be assessed by quantifying free fatty acid release or triglyceride hydrolysis [4,8].
Transcriptomics and proteomics
RNA-seq and proteomics can identify genes and proteins differentially expressed during lipophagy induction or inhibition [5,6]. For example, proteomic analysis of lipid droplet fractions from macrophages identified novel lipophagy regulators.
CRISPR screens
Genome-wide CRISPR knockout or activation screens can uncover novel regulators of lipophagy. Cells are challenged with lipid overload, and lipid droplet content is measured by high-content imaging to identify genes that alter lipophagy.
How CRISPR Can Be Used to Study GO:0061724 lipophagy
Knockout
CRISPR knockout of core autophagy genes (e.g., ATG5, ATG7) or lipid droplet proteins (e.g., PLIN2) is used to test their requirement for lipophagy [5,6]. Knockout cell lines can be generated in hepatocytes, macrophages, or microglia to study disease-relevant phenotypes [1,4].
Point Mutation
Point mutations in genes such as LIPA or ASIC1 can be introduced via CRISPR to model human disease variants and assess their impact on lipophagy [5,7]. Isogenic cell lines carrying specific mutations allow precise structure-function studies.
Knock-in
Knock-in of fluorescent tags (e.g., GFP-LC3) or epitope tags at endogenous loci enables real-time tracking of lipophagy components. Knock-in of disease-associated mutations (e.g., in LIPA) recapitulates patient phenotypes in cell models.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes such as BECN1 or TFEB can enhance lipophagy and rescue lipid accumulation. Overexpression models are useful for gain-of-function studies and therapeutic target validation.
How EDITGENE Supports lipophagy Research
Researchers studying lipophagy-related genes often need to determine whether a candidate gene is causally involved in lipid droplet turnover, and to dissect the precise molecular mechanisms by which it acts. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and knock-in of reporters.
Contact EDITGENE today to design your custom CRISPR model for lipophagy research.
Frequently Asked Questions About lipophagy
What is lipophagy?
Lipophagy is the selective degradation of lipid droplets by macroautophagy, a process that mobilizes stored lipids for energy or secretion.
What is GO:0061724?
GO:0061724 is the Gene Ontology identifier for lipophagy, defined as the selective degradation of lipid droplets by macroautophagy.
What genes are involved in lipophagy?
Key genes include ATG5, ATG7, LC3B, PLIN2, PLIN3, Rab7, TREM1, ASIC1, RIP1, and LIPA, among others [1,4,5,6,7].
How is lipophagy regulated?
Lipophagy is regulated by nutrient-sensing pathways such as mTORC1 and AMPK, and by lipid droplet-associated proteins like PLIN2 and PLIN3 [5,6].
What diseases are linked to lipophagy?
Impaired lipophagy is linked to atherosclerosis, nonalcoholic steatohepatitis, and diabetes-associated cognitive impairment [1,2,3,4,7].
How can I study lipophagy in the lab?
Common methods include fluorescence microscopy with BODIPY and LC3, Western blot for LC3-II, and CRISPR screens [5,6].
What is the role of lipophagy in atherosclerosis?
Lipophagy promotes cholesterol efflux from macrophage foam cells; its impairment leads to lipid accumulation and plaque formation [2,3,6,7].
Can CRISPR be used to study lipophagy?
Yes, CRISPR knockout, knock-in, point mutation, and overexpression models are widely used to dissect lipophagy gene function [5,6].
What is the difference between lipophagy and lipolysis?
Lipophagy involves autophagic delivery of lipid droplets to lysosomes, while lipolysis is direct enzymatic hydrolysis by cytosolic lipases.
Which cell types are best for studying lipophagy?
Hepatocytes, macrophages, and microglia are commonly used, as they are highly relevant to metabolic and inflammatory diseases [1,4,6].
Conclusion
Lipophagy (GO:0061724) is a fundamental selective autophagy pathway that controls lipid droplet turnover and cellular energy homeostasis. Its dysregulation contributes to atherosclerosis, NASH, and diabetes-associated cognitive impairment, making it an attractive therapeutic target [1,2,3,4,7]. Advances in CRISPR-based gene editing and high-content imaging are accelerating the discovery of novel lipophagy regulators and their mechanisms [5,6]. Continued research into lipophagy will likely yield new strategies for treating metabolic and cardiovascular diseases.
References
- 1. Li Q et al.. 2023. Impaired lipophagy induced-microglial lipid droplets accumulation contributes to the buildup of TREM1 in diabetes-associated cognitive impairment.. Autophagy 19(10):2639-2656 PMID: 37204119
- 2. Laval T et al.. 2023. A role for lipophagy in atherosclerosis.. Nat Rev Cardiol 20(7):431-432 PMID: 37161064
- 3. Liu Q et al.. 2020. Lipophagy in atherosclerosis.. Clin Chim Acta 511:208-214 PMID: 33096029
- 4. Minami Y et al.. 2023. Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion.. Nat Commun 14(1):4084 PMID: 37443159
- 5. Zhang S et al.. 2022. The regulation, function, and role of lipophagy, a form of selective autophagy, in metabolic disorders.. Cell Death Dis 13(2):132 PMID: 35136038
- 6. Robichaud S et al.. 2021. Identification of novel lipid droplet factors that regulate lipophagy and cholesterol efflux in macrophage foam cells.. Autophagy 17(11):3671-3689 PMID: 33590792
- 7. Wang YM et al.. 2024. ASIC1/RIP1 accelerates atherosclerosis via disrupting lipophagy.. J Adv Res 63:195-206 PMID: 37931656
- 8. Cui W et al.. 2021. Lipophagy-derived fatty acids undergo extracellular efflux via lysosomal exocytosis.. Autophagy 17(3):690-705 PMID: 32070194
